GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:IMNP
Delisted

Immune Pharmaceuticals Inc. Stock Signals

$0.0032
+0 (+0%)
At Close: Mar 05, 2019

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -3.650 13 days ( 53.62 % )
Last Price $0.0032 0 %
High/ Low $0.0032 - $0.0032 0%
Chg 7 Days N/A $0.0032 $0.0032
Chg 30 Days -57.33 % $0.0075 $0.0032
Chg 12 mos -99.16 % $0.380 $0.0032
Trend - 3 mos -58.31 % Width: 285.52 %
Trend - 12 mos -96.53 % Width: 108.29 %
Pred. range - 3 mos N/A - $0.0033 -100.00 % - 4.22 %
Pred. range - 12 mos N/A - $0.0005 -100.00 % - -83.73 %
Short MA avg 3 mos Sell 2019-02-07 - 18 days
Long MA avg 3 mos Sell 2019-02-14 - 13 days
Short/Long MA avg 3 mos Sell 2019-02-15 - 12 days
Short MA avg 12 mos Sell 2019-02-07 - 18 days
Long MA avg 12 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 12 mos Sell 0000-00-00 - N/A days
Pivot Short Buy 2019-02-19 - 11 days
Bollinger Sell 0000-00-00 - N/A days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Immune Pharmaceuticals Inc.

Immune Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops and commercializes novel targeted therapeutics in the immuno-inflammation and immuno-oncology areas. The company’s lead product candidate is Bertilimumab, a human monoclonal antibody, which is in Phase II clinical trial for the treatment of ulcerative colitis, bullous pemphigoid, and Crohn's disease. It is also developing NanoCyclo, a topical nanocapsule formulati... IMNP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT